Evidence map›Paper›PMID 25222894›Full record

Trial reportInfection control and hospital epidemiology2014

Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial.

Susan S Huang, Edward Septimus, Taliser R Avery, Grace M Lee, Jason Hickok, Robert A Weinstein, Julia Moody, Mary K Hayden, Jonathan B Perlin, Richard Platt and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Infection control and hospital epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Chlorhexidine gluconate bathing of adult patients in intensive care units in São Paulo, Brazil: Impact on the incidence of healthcare-associated infection.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Trial
  3. Article
  4. Article
  5. Article
  6. Efficient processing of MRSA screening specimens by a modified inoculation protocol.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Reply to O'Riordan et al.Infection control and hospital epidemiology · 2015
    Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Susan S HuangDivision of Infectious Diseases and Health Policy Research Institute, University of California Irvine School of Medicine, Orange, California.
Edward Septimus
Taliser R Avery
Grace M Lee
Jason Hickok
Robert A Weinstein
Julia Moody
Mary K Hayden
Jonathan B Perlin
Richard Platt
G Thomas Ray
HCA Healthcare · USHarvard Pilgrim Health Care · USCook County Health and Hospitals System · USHarvard University · USKaiser Permanente · USRush University Medical Center · USUniversity of California, Irvine · US

Funding

Eastern Massachusetts Prevention Epicenters Program IIU01CI000344 · CI · HARVARD PILGRIM HEALTH CARE, INC. · PI PLATT, RICHARD · 2006 to 2010
$1.8M
Intramural CDC HHS CC999999NCPDCID CDC HHS 1U01 CI000344NCPDCID CDC HHS U01 CI000344
6 · The paper itself

Abstract

objectiveTo estimate and compare the impact on healthcare costs of 3 alternative strategies for reducing bloodstream infections in the intensive care unit (ICU): methicillin-resistant Staphylococcus aureus (MRSA) nares screening and isolation, targeted decolonization (ie, screening, isolation, and decolonization of MRSA carriers or infections), and universal decolonization (ie, no screening and decolonization of all ICU patients).

designCost analysis using decision modeling.

methodsWe developed a decision-analysis model to estimate the health care costs of targeted decolonization and universal decolonization strategies compared with a strategy of MRSA nares screening and isolation. Effectiveness estimates were derived from a recent randomized trial of the 3 strategies, and cost estimates were derived from the literature.

resultsIn the base case, universal decolonization was the dominant strategy and was estimated to have both lower intervention costs and lower total ICU costs than either screening and isolation or targeted decolonization. Compared with screening and isolation, universal decolonization was estimated to save $171,000 and prevent 9 additional bloodstream infections for every 1,000 ICU admissions. The dominance of universal decolonization persisted under a wide range of cost and effectiveness assumptions.

conclusionsA strategy of universal decolonization for patients admitted to the ICU would both reduce bloodstream infections and likely reduce healthcare costs compared with strategies of MRSA nares screening and isolation or screening and isolation coupled with targeted decolonization.

Indexed as

Cost SavingsMethicillin-Resistant Staphylococcus aureusAdultBacteremiaCarrier StateCross InfectionHospital CostsHumansIntensive Care UnitsLength of StayMass ScreeningNasal CavityStaphylococcal Infections

Identifiers

PMID25222894
PMCPMC10920056
OpenAlexW2055766532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.